204 related articles for article (PubMed ID: 32770377)
21. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging.
Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K
In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367
[TBL] [Abstract][Full Text] [Related]
22. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide.
Shetty AS; Fraum TJ; Ballard DH; Hoegger MJ; Itani M; Rajput MZ; Lanier MH; Cusworth BM; Mehrsheikh AL; Cabrera-Lebron JA; Chu J; Cunningham CR; Hirschi RS; Mokkarala M; Unteriner JG; Kim EH; Siegel CL; Ludwig DR
Radiographics; 2023 Jul; 43(7):e220209. PubMed ID: 37319026
[TBL] [Abstract][Full Text] [Related]
23. MRI radiomics-based nomogram for individualised prediction of synchronous distant metastasis in patients with clear cell renal cell carcinoma.
Bai X; Huang Q; Zuo P; Zhang X; Yuan J; Zhang X; Wang M; Xu W; Ye H; Zhao J; Sun H; Shao B; Wang H
Eur Radiol; 2021 Feb; 31(2):1029-1042. PubMed ID: 32856163
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of MRI for Solid Renal Masses: A Systematic Review and Meta-analysis.
Frank RA; Dawit H; Bossuyt PMM; Leeflang M; Flood TA; Breau RH; McInnes MDF; Schieda N
J Magn Reson Imaging; 2023 Apr; 57(4):1172-1184. PubMed ID: 36054467
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
26. Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma.
Li Q; Liu YJ; Dong D; Bai X; Huang QB; Guo AT; Ye HY; Tian J; Wang HY
J Magn Reson Imaging; 2020 Nov; 52(5):1557-1566. PubMed ID: 32462799
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
28. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
29. Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy.
Peabody H; Lane BR; Qi J; Kim T; Montie JE; Moriarity A; Brede CM; Montgomery J;
World J Urol; 2021 Mar; 39(3):779-785. PubMed ID: 32361876
[TBL] [Abstract][Full Text] [Related]
30. Kidney scoring surveillance: predictive machine learning models for clear cell renal cell carcinoma growth using MRI.
Yazdian Anari P; Zahergivar A; Gopal N; Chaurasia A; Lay N; Ball MW; Turkbey B; Turkbey E; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2024 Apr; 49(4):1202-1209. PubMed ID: 38347265
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma.
Beddy P; Genega EM; Ngo L; Hindman N; Wei J; Bullock A; Bhatt RS; Atkins MB; Pedrosa I
Clin Genitourin Cancer; 2014 Feb; 12(1):55-62. PubMed ID: 24145001
[TBL] [Abstract][Full Text] [Related]
34. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.
Kay FU; Canvasser NE; Xi Y; Pinho DF; Costa DN; Diaz de Leon A; Khatri G; Leyendecker JR; Yokoo T; Lay AH; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
Radiology; 2018 May; 287(2):543-553. PubMed ID: 29390196
[TBL] [Abstract][Full Text] [Related]
36. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.
Rais-Bahrami S; Siddiqui MM; Turkbey B; Stamatakis L; Logan J; Hoang AN; Walton-Diaz A; Vourganti S; Truong H; Kruecker J; Merino MJ; Wood BJ; Choyke PL; Pinto PA
J Urol; 2013 Nov; 190(5):1721-1727. PubMed ID: 23727310
[TBL] [Abstract][Full Text] [Related]
37. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
38. Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.
Xi Y; Yuan Q; Zhang Y; Madhuranthakam AJ; Fulkerson M; Margulis V; Brugarolas J; Kapur P; Cadeddu JA; Pedrosa I
Eur Radiol; 2018 Jan; 28(1):124-132. PubMed ID: 28681074
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
[TBL] [Abstract][Full Text] [Related]
40. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
